These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 17630556)

  • 21. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS.
    Pierre R; Steel-Duncan JC; Evans-Gilbert T; Rodriguez B; Palmer P; Smikle MF; Whorms S; Hambleton I; Figueroa JP; Christie CD
    West Indian Med J; 2004 Oct; 53(5):315-21. PubMed ID: 15675497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART).
    Chiriboga CA; Fleishman S; Champion S; Gaye-Robinson L; Abrams EJ
    J Pediatr; 2005 Mar; 146(3):402-7. PubMed ID: 15756229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.
    Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A
    Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.
    Warszawski J; Lechenadec J; Faye A; Dollfus C; Firtion G; Meyer L; Douard D; Monpoux F; Tricoire J; Benmebarek Y; Rouzioux C; Blanche S
    Clin Infect Dis; 2007 Sep; 45(6):785-94. PubMed ID: 17712765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of patients diagnosed with advanced HIV in the HAART era--OMEGA Cohort.
    Santos J; Palacios R; Ruiz J; González M; Márquez M
    Int J STD AIDS; 2005 Mar; 16(3):252-5. PubMed ID: 15829028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
    Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
    AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
    Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
    HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.
    Kumarasamy N; Solomon S; Chaguturu SK; Cecelia AJ; Vallabhaneni S; Flanigan TP; Mayer KH
    Clin Infect Dis; 2005 Nov; 41(10):1525-8. PubMed ID: 16231268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
    Alvaro-Meca A; Micheloud D; Jensen J; Díaz A; García-Alvarez M; Resino S
    Pediatr Infect Dis J; 2011 Sep; 30(9):764-8. PubMed ID: 21494172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC; Wong KH; Lee SS
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan.
    Hung CC; Hsiao CF; Chen MY; Hsieh SM; Chang SY; Sheng WH; Sun HY; Chang SC
    Jpn J Infect Dis; 2006 Aug; 59(4):222-8. PubMed ID: 16936339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.
    Curran A; Falcó V; Crespo M; Martinez X; Ribera E; Villar del Saz S; Imaz A; Coma E; Ferrer A; Pahissa A
    HIV Med; 2008 Oct; 9(8):609-15. PubMed ID: 18557951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.